When the world gets closer.

We help you see farther.

Sign up to our expressly international daily newsletter.

Already a subscriber? Log in.

You've reached your limit of one free article.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Exclusive International news coverage

Ad-free experience NEW

Weekly digital MagazineNEW

9 daily & weekly Newsletters

Access to Worldcrunch archives

Free trial

30-days free access, then $2.90
per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch
Geopolitics

As Hopes For Iran Nuclear Deal Fade, Uranium Enrichment Accelerates

Institute for Science and International Security concludes that Iran is enriching uranium at a 60% level, with new centrifuges meaning that Tehran is a month away from obtaining arms-grade material to move toward its first weapon.

Photo of Iran's President Ebrahim Raisi walking on a stage in front of Iranian flags

Iran's President Ebrahim Raisi, elected in August 2021

Ahmad Ra'fat

-Analysis-

The U.S.-based Institute for Science and International Security, which includes independent nuclear power experts, concludes from information issued by the International Atomic Energy Agency (IAEA) that Iran is enriching uranium at a 60% level — and thanks to new types of centrifuges, Tehran is barely a month away from obtaining weapons-grade material. The specialists caution that weapons-grade uranium is not the same as a nuclear bomb, for which delivery weapons and assemblage are needed. That would require another two years.

The Institute's experts believe Iran could produce material for a second bomb within a three-month time frame and that unless its activities are slowed, it may have enough enriched uranium for three bombs in the next five months.


Yet European states have shown unjustified optimism after a recent trip to Tehran by IAEA chief Rafael Grossi, and his meeting with Mohammad Eslami, the new head of Iran's Atomic Energy Organization. Grossi achieved very little in terms of reducing Iran's enrichment activities, merely ensuring the IAEA's renewed access to its cameras in installations there. Their recordings remain in Iranian hands.

Sabotage and cyberattacks haven't stopped progress

Instead, the visit helped Iran to halt at the last minute a threat by Britain, France and Germany to present the IAEA board of governors with a draft resolution to resend Iran's dossier to the UN Security Council for violating its non-proliferation obligations.

The IAEA had made further concessions. In past months, it kept quiet about reports of abusive conduct in Iran toward female IAEA inspectors, protesting only once the incidents were reported in The Wall Street Journal.

The Institute for Science and International Security also believes the acts of sabotage and cyberattacks of past months reportedly carried out by Israel and the United States, have failed to significantly interrupt Iran's program, merely slowing activities at certain locations. Tehran managed to rapidly repair the damage done, and resume its activities. The report concludes that Iran is as close today as it has ever been to accessing a bomb.

File photo of former Iranian President Rouhani and Head of the Atomic Energy Organization of Iran Ali Akbar Salehi visit an exhibition of the Atomic Energy Organization of Iran (AEOI) achievements.— Photo: Salampix/Abaca/ZUMA

Keep an eye on Ali Baqeri-Kani

It is not currently clear when Iran and the West will resume talks on Tehran's program. With the rise of hardline officials in Iran — from President Ibrahim Raisi to his foreign minister, Hossein Amir'abdollahian and the country's new nuclear chief, Mohammad Eslami — it seems unlikely the West will get the same terms as the 2015 pact that included the United States.

Western states are particularly concerned by Iran's new negotiator, Ali Baqeri-Kani, who replaces Abbas Araqchi. Baqeri's father heads some of the regime's powerful financial and cultural foundations and his brother, Mesbahulhuda, is a son-in-law to the Supreme Leader Ali Khamenei. He has several times voiced his opposition to any type of compromise with the West.

From 2007 to 2013, he was in the negotiation team led by Sa'id Jalili, when talks with the West yielded nothing for Iran but more and tougher sanctions. Today, the prospects of reviving the 2015 pact have dimmed. Its moribund state may even have cheered Israel into recently softening its vociferous opposition to a pact with Tehran.

Observers suspect more concessions to Iran may be afoot, to prevent the pact's demise. Some believe the Islamic Republic may be changing its entire nuclear policy, and its refusal to return to Vienna has little to do with a new president but with a firm belief that it must return with its "hands full." Dangling its considerable advances toward a nuclear weapon, Iran could then stop its activities at the last minute, in return for major concessions, like the lifting of most sanctions and foregoing any talks about its ballistic program or regional interventions.

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Society

Psychedelics For PTSD? Tests In The World's Latest Wars, From Ukraine To Afghanistan

Psychedelic-assisted MDMA therapy for PTSD has shown some promise in the West, but plans to export it globally may be premature.

A US soldier

Could MDMA-assisted therapy help with PTSD?

Tech. Sgt. Michael R. Holzworth
Jonathan Moens

When the war in Ukraine broke out, many countries and agencies around the world lent their support in the form of financial aid, weapons, and food. But Olga Chernoloz, a Ukrainian neuroscientist based in Canada, wanted to provide a different kind of assistance: a combination of therapy and the psychedelic drug MDMA.

Such therapy, she said, could help countless people on the ground who are suffering from psychological trauma. “I thought that the most efficacious way I could be of help,” she told Undark, “would be to bring psychedelic-assisted therapy to Ukraine.” Chernoloz’s confidence stems in part from the results of clinical trials on MDMA to treat post-traumatic stress disorder in vulnerable populations, which suggest that such treatments may improve symptoms, or do away with them altogether. But the approach is experimental and has not yet cleared major regulatory hurdles in Canada, Europe, or the United States.

Still, Chernoloz, who is a professor at the University of Ottawa, plans on carrying out clinical trials with Ukrainian refugees in a psychedelic center in the Netherlands in early 2024.

This month, Chernoloz and her colleagues organized an education session for 20 Ukrainian therapists to learn about MDMA-assisted therapy for PTSD from the Multidisciplinary Association for Psychedelic Studies, or MAPS, one of the most influential organizations dedicated to education and promotion of psychedelic drugs.

Keep reading...Show less

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Already a subscriber? Log in.

You've reached your limit of one free article.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Exclusive International news coverage

Ad-free experience NEW

Weekly digital MagazineNEW

9 daily & weekly Newsletters

Access to Worldcrunch archives

Free trial

30-days free access, then $2.90
per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch

The latest